Physician profile
Adelbert Wadsworth
NPI 1699053660
$10,625.81
in general payments reported to CMS, 2019-2025
36 companies · $2,304 in 2025
The $2,304 reported for 2025 was more than what 93% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,025 · 2022: $2,248 · 2023: $1,796 · 2024: $2,252 · 2025: $2,304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,992 · Travel and Lodging: $183 · Education: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,992.40 |
| Travel and Lodging | $183.36 |
| Education | $176.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,520.19 | 2021-2025 | Xtandi, Myrbetriq, Veozah |
| Teleflex LLC | $1,347.07 | 2021-2025 | Urolift, Solesta |
| Sumitomo Pharma America, INC. | $1,114.51 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $879.33 | 2021-2025 | Provenge |
| Janssen Biotech, INC. | $648.31 | 2021-2025 | Erleada, Akeega |
| Antares Pharma, INC. | $516.58 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Boston Scientific Corporation | $491.60 | 2023-2025 | Rezum Generator, Spaceoar Vue System - 10ml, Lithovue |
| Procept Biorobotics Corporation | $442.95 | 2022-2024 | Aquabeam System |
| Urogen Pharma, INC. | $424.21 | 2021-2025 | Jelmyto |
| Abbvie INC. | $401.43 | 2023-2025 | |
| Urovant Sciences INC | $347.96 | 2021-2022 | |
| Coloplast Corp | $321.28 | 2021-2025 | Speedicath |
| Pfizer INC. | $244.91 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $232.98 | 2022-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $188.30 | 2021-2024 | Xiaflex |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $177.43 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $175.19 | 2021-2025 | |
| Blue Earth Diagnostics | $142.41 | 2021-2025 | Posluma |
| Axonics, INC. | $138.01 | 2023 | Axonics |
| Myovant Sciences INC. | $123.79 | 2021-2022 | |
| 180 Medical, INC. | $121.92 | 2021-2025 | |
| Endo USA, INC. | $91.35 | 2024-2025 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $87.48 | 2022-2024 | Keytruda, Welireg, Lynparza |
| Novartis Pharmaceuticals Corporation | $83.03 | 2025 | |
| Progenics Pharmaceuticals, INC. | $49.07 | 2022-2023 | Pylarify |
| Halozyme INC | $47.25 | 2023 | |
| Rochester Medical Corporation | $45.03 | 2022 | |
| Sun Pharmaceutical Industries INC. | $43.46 | 2022-2023 | Yonsa |
| Hollister Incorporated | $37.71 | 2022-2023 | Vapro, Infyna Chic |
| Amgen INC. | $33.28 | 2021-2022 | |
| Tolmar, INC. | $21.54 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $20.64 | 2022 | |
| Palette Life Sciences, INC. | $17.18 | 2022 | |
| Immunitybio, INC. | $17.10 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.31 | 2022 | |
| Mission Pharmacal Company | $15.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adelbert Wadsworth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.